Aswan University Hospital
aswu.edu.egTotal trials
95
Active
3
Phase 3
2
Total enrollment
16,284
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Botulinum toxin A | — | — | — | — | — | 1 | |
| Tadalafil 5mg | — | — | — | — | — | 1 | |
| full dose of Neostigmine | — | — | — | — | — | 1 | |
| half dose of Neostigmine | — | — | — | — | — | 1 | |
| Femoral nerve block with0.25% bupivacaine guided by ultrasound. | — | — | — | — | — | 1 | |
| PENG block with0.25% bupivacaine guided by ultrasound. | — | — | — | — | — | 1 | |
| Preoperative IV fentanyl 100microgram | — | — | — | — | — | 1 |
Next readouts
- 2024-11-01
- 2025-08-31
- 2026-01
Top conditions
- Cesarean Section Complications19
- IUCD Complication8
- Placenta Previa7
- Infertility, Female5
- Postoperative Pain4
- Pre-Eclampsia3
- Preeclampsia3
- Acquired Deformity of Elbow2
Frequently asked questions about Aswan University Hospital
- How many clinical trials does Aswan University Hospital have on ClinicalTrials.gov?
- Aswan University Hospital is listed as the lead sponsor on 95 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Aswan University Hospital's trials are in Phase 3?
- 2 of Aswan University Hospital's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Aswan University Hospital focus on?
- Aswan University Hospital's most-studied conditions on ClinicalTrials.gov are Cesarean Section Complications, IUCD Complication, Placenta Previa, Infertility, Female, Postoperative Pain.
- When are Aswan University Hospital's next clinical trial readouts?
- Aswan University Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl”, expected around 2024-11-01.